Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Go back to Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza| Assisted Living Concepts, Inc. New (NYSE: ALC) | Delayed: 73.58 -1.77 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.35 | 52 Week High | $14.66 | |||
| Open | $72.34 | 52 Week Low | $6.93 | |||
| Day High | $73.88 | P/E | N/A | |||
| Day Low | $72.09 | EPS | $-1.75 | |||
| Volume | 2,945,280 | |||||
| Assisted Living Concepts, Inc. New (NYSE: ALC) | Delayed: 73.58 -1.77 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.35 | 52 Week High | $14.66 | |||
| Open | $72.34 | 52 Week Low | $6.93 | |||
| Day High | $73.88 | P/E | N/A | |||
| Day Low | $72.09 | EPS | $-1.75 | |||
| Volume | 2,945,280 | |||||

